Leading global stakeholders will gather at HempToday Center in Poland Aug. 24-25, 2018 to survey the burgeoning medical hemp sector amid exploding demand worldwide for CBD.
European blue-chip CBD brand CannabiGold is the host sponsor for “The Future of Medical Hemp,” an exclusive gathering limited to 25 persons total. Twenty accreditations are still available for the Summit at €900 each. Signups before the end of June receive an early-bird rate of €700.
Attendees will get an in-depth look at a wide range of industry topics including investment, product development & innovation, global medical hemp hot spots, the regulatory environment, biochemistry of cannabinoids, and cannabinoid production.
Featured presenters are:
Boaz Wachtel, Chairman & co-founder, CresoPharma, a nutraceuticals company traded on the Australian Securities Exchange (ASX) since autumn 2016. Wachtel was co-founder and former managing director of MMJ Phytotech, Australia’s first publicly traded medical cannabis company. He is also the co-founder of the International Medical Cannabis Patient Coalition (IMCPC).